唾液消化酶生物标志物在咽喉反流病中的准确性与临床表现
研究前瞻性纳入123例经24小时下咽-食管多通道腔内阻抗-pH监测诊断的咽喉反流病患者和48例无症状成人,检测唾液胃蛋白酶、弹性蛋白酶、胆固醇、胆汁酸、胰蛋白酶、胰脂肪酶和胃脂肪酶。唾液胆固醇诊断性能最优(AUC=0.989,阈值2.05 mg/dL),弹性蛋白酶次之(AUC=0.811,阈值>49.2 μg/mL),胆固醇与3个月反流症状评分正相关(r=0.538)。
要点
- 唾液胆固醇诊断咽喉反流病AUC=0.989,阈值2.05 mg/dL时灵敏度100%、特异度94.3%。
- 唾液弹性蛋白酶AUC=0.811,阈值>49.2 μg/mL,诊断性能中等至较高。
- 反流症状评分>13联合唾液pH诊断准确(灵敏度88.8%、特异度97.1%)。
核心结论
- 唾液胆固醇、弹性蛋白酶和唾液pH是咽喉反流病有前景的诊断生物标志物,准确性优于其他消化酶,并可能预测治疗结局。
研究设计与样本
- 前瞻性研究,2020年1月至2024年5月从两家欧洲医院连续招募经24小时下咽-食管多通道腔内阻抗-pH监测诊断的咽喉反流病患者123例,对照组为无症状成人48例。
主要发现
- 患者唾液pH和弹性蛋白酶水平显著升高,胆固醇降低,与对照组相比。
- 唾液胆固醇诊断性能最优,AUC=0.989,阈值2.05 mg/dL时灵敏度100%、特异度94.3%。
- 弹性蛋白酶诊断性能中等至较高,AUC=0.811,阈值>49.2 μg/mL。
- 反流症状评分>13联合唾液pH诊断准确,灵敏度88.8%、特异度97.1%。
- 胆固醇与3个月反流症状评分正相关(r=0.538)。
关键数值与推荐
- 唾液胆固醇阈值2.05 mg/dL,AUC=0.989,灵敏度100%,特异度94.3%。
- 唾液弹性蛋白酶阈值>49.2 μg/mL,AUC=0.811。
- 反流症状评分>13联合唾液pH:灵敏度88.8%,特异度97.1%。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the diagnostic performance of multiple digestive enzyme biomarkers in detecting and characterizing laryngopharyngeal reflux disease (LPRD). METHODS: Patients with LPRD at the 24-h hypopharyngeal-esophageal multichannel intraluminal impedance-pH testing (HEMII-pH) were consecutively recruited from January 2020 to May 2024 from two European hospitals. The control group consisted of adults without symptoms. Prospective clinical data collection included demographics, gastrointestinal endoscopy, HEMII-pH, reflux symptom score (RSS), and reflux sign assessment (RSA) findings. At baseline, pepsin, elastase, cholesterol, bile acids, trypsin, pancreatic, and gastric lipase were measured in saliva samples of LPRD patients and asymptomatic individuals. Sensitivity, specificity, positive and negative predictive values, and diagnostic accuracy (receiver operating characteristic (ROC) curve and area under the curve (AUC)) were evaluated. RESULTS: One hundred and twenty-three patients and forty-eight asymptomatic individuals were prospectively recruited. Patients exhibited significantly elevated salivary pH and elastase levels, but decreased cholesterol compared to controls. Salivary cholesterol demonstrated superior diagnostic performance (AUC = 0.989), with a 2.05 mg/dL threshold yielding excellent sensitivity (100%), specificity (94.3%), and predictive values. Elastase showed moderate-to-high diagnostic performance (AUC = 0.811, threshold > 49.2 μg/mL). Combined RSS > 13 and salivary pH demonstrated robust diagnostic accuracy (SE = 88.8%, SP = 97.1%). Cholesterol positively correlated with 3-month RSS (r = 0.538). CONCLUSION: Salivary cholesterol, elastase, and the salivary pH emerge as promising diagnostic biomarkers for LPRD, demonstrating superior accuracy to other digestive enzymes and potential value in predicting treatment outcomes. LEVEL OF EVIDENCE: III.
引用
- Lechien JR, El Ayoubi M, Muls V, et al. Accuracy and Clinical Findings of Saliva Digestive Biomarkers in Laryngopharyngeal Reflux Disease. Laryngoscope. 2025. PMID: 40833239. doi:10.1002/lary.70062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。